GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Royalty Pharma PLC (STU:RPD) » Definitions » Investments And Advances

Royalty Pharma (STU:RPD) Investments And Advances : €14,549 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Royalty Pharma Investments And Advances?

Royalty Pharma's Investments And Advances for the quarter that ended in Mar. 2025 was €14,549 Mil.

Royalty Pharma's quarterly Investments And Advances increased from Sep. 2024 (€14,601 Mil) to Dec. 2024 (€15,650 Mil) but then declined from Dec. 2024 (€15,650 Mil) to Mar. 2025 (€14,549 Mil).

Royalty Pharma's annual Investments And Advances increased from Dec. 2022 (€13,432 Mil) to Dec. 2023 (€13,848 Mil) and increased from Dec. 2023 (€13,848 Mil) to Dec. 2024 (€15,650 Mil).

Royalty Pharma Investments And Advances Historical Data

The historical data trend for Royalty Pharma's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Royalty Pharma Investments And Advances Chart

Royalty Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial 10,920.04 12,945.64 13,432.11 13,847.74 15,649.63

Royalty Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,401.35 13,981.37 14,600.94 15,649.63 14,548.68

Royalty Pharma Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Royalty Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Royalty Pharma PLC (STU:RPD) » Definitions » Investments And Advances
Comparable Companies
INSM BMRN INCY SMMT MRNA EXEL ASND TECH ROIV CORT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
RPRX:USA RPRX:Mexico
Address
110 East 59th Street, New York, NY, USA, 10022
Website
https://www.royaltypharma.com
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.